Krystalbio
Pittsburgh, US · Founded 2017 · 3 known investors
Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.
Founders & leadership
Krystalbio was founded in 2017 by Suma M. Krishnan, Krish S. Krishnan, Suma Krishnan, and Krish Krishnan.
SM
Suma M. KrishnanCo-founder
KS
Krish S. KrishnanChairman & CEO
SK
Suma KrishnaninPresident, Research & Development
KK
Krish KrishnaninChairman & CEO
DN
Doug NorbyNamed on SEC filing
DR
Dino RossiNamed on SEC filing
Board
DJ
Investors · 3
Reported raises · per SEC filings
Form D private placements$11.3M disclosed across 1 round · 2017
▶$11.3MraisedAug 2017 · 16 investors · BiotechnologyRule 506(b)
▶$11.3MraisedAug 2017 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Doug NorbyDirector
- Dan JanneyDirector
- Dino RossiDirector
- Suma M. KrishnanDirector
- Krish S. KrishnanExecutive Officer, Director
- Offering amount
- $11.3M
- Amount sold
- $11.3M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Inven104 shared keywordsInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.
Aro Biotherapeutics90 shared keywordsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Companies competing with Krystalbio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Krystalbio do?
- Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.
- Who founded Krystalbio?
- Krystalbio was founded by Suma M. Krishnan, Krish S. Krishnan, Suma Krishnan, Krish Krishnan in 2017.
- Who are Krystalbio's investors?
- Krystalbio's investors include Avoro Capital Advisors, Frazier Life Sciences, Alta Partners.
- How much funding has Krystalbio raised?
- Krystalbio has disclosed $11.3M raised across 1 round.
- Where is Krystalbio headquartered?
- Krystalbio is headquartered in Pittsburgh, US.